Alzheimer’s Disease: Medical History

The case history (medical history) represents an important component in the diagnosis of Alzheimer’s disease.

Usually, it is an extraneous history (family members).

Family history

  • Is there frequent dementia in your family?

Social history

  • What is your profession/have you practiced?
  • Is there any evidence of psychosocial stress or strain due to your family situation?

Current medical history/systemic history (somatic and psychological complaints).

  • Have you noticed any symptoms such as memory problems, restlessness, or irritability?
  • How long have these symptoms been present?
  • Are there additional mood swings, delusions* * , hallucinations* * , or sleep disturbances?
  • Is there a loss of appetite and/or weight loss?
  • Are there additional neurological disorders such as paralysis?* * .

Vegetative anamnesis incl. nutritional anamnesis.

  • Are you overweight? Please tell us your body weight (in kg) and height (in cm).
  • Do you have a balanced diet?
    • Intake of saturated or trans-saturated fats (the fats are found in margarine, for example)?
    • Low consumption of fruits, vegetables, fish, and omega-3-rich oils leads to increased risk of dementia and Alzheimer’s disease in non-ApoE subjects
  • Do you get enough exercise every day?
  • Do you smoke? If so, how many cigarettes, cigars or pipes per day?
  • Do you drink alcohol? If yes, what drink(s) and how many glasses per day?
  • Do you use drugs? If yes, what drugs and how often per day or per week?

Self history incl. medication history.

  • Pre-existing conditions (neurological, psychiatric diseases).
  • Operations
  • Allergies

Medication history

  • Benzodiazepines – are associated with a 51% increased rate of Alzheimer’s disease when prescribed at > 91 daily doses.In a cohort study of over 4700 participants, medication use in the 10 years prior to study entry was reliably determined from prescription data, and participants’ cognitive performance was assessed every 2 years. Study participants were on average 74 years old at baseline. The study design suggests that dementia is driving benzodiazepine use, rather than the other way around.
  • ACE inhibitor*
  • Antiepileptic drugs*
  • Diuretics*
  • Hormone ablative therapy (HAT; synonyms: Hormone ablation; androgen deprivation therapy, ADT; hormone therapy that withholds the male sex hormone testosterone); multivariate analysis: risk increased by 66%.
  • Proton pump inhibitors (PPIs; acid blockers) in elderly patients.

Environmental history

  • Aluminum?; contra
  • Air pollutants: particulate matter (PM2.5) – 13% increased risk of disease per 5 µg/m3 increase in particulate matter at residence (hazard ratio 1.13; 1.12 to 1.14); association was dose-dependent up to a PM2.5 concentration of 16 µg/m3.
  • Copper.
  • Manganese

* These can lead to drug-induced hyponatremia (sodium deficiency), resulting in secondary dementia. * * If this question has been answered with “Yes”, an immediate visit to the doctor is required! (Data without guarantee)